Author:
Hillier Morgan,El-Baba Mazen,Owen James R. M.
Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Tan DH, Hull MW, Yoong D, Tremblay C, O’Byrne P, Thomas R, et al. Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis. CMAJ. 2017;189(47):E1448–58.
2. Armstrong WS, Guarner J, Kraft CS, Caliendo AM. Human immunodeficiency virus. In: Diagnostic microbiology of the immunocompromised host, vol. 15; 2016. p. 51–68.
3. Bavinton BR, Pinto AN, Phanuphak N, Grinsztejn B, Prestage GP, Zablotska-Manos IB, Jin F, Fairley CK, Moore R, Roth N, Bloch M. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV. 2018;5(8):e438–47.
4. Lee PK, Kieffer TL, Siliciano RF, Nettles RE. HIV-1 viral load blips are of limited clinical significance. J Antimicrob Chemother. 2006;57(5):803–5.
5. Centres For Disease Control and Prevention, U.S. Department of Health and Human Services. Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV - United States, 2016 [Internet]. Atlanta; 2016. 91p. Available from: https://www.cdc.gov/hiv/pdf/programresources/cdc-hiv-npep-guidelines.pdf. Cited 8 Apr 2020